HEALTHTECH INTERNATIONAL INC
10-Q/A, 1996-12-10
SPORTING & ATHLETIC GOODS, NEC
Previous: US AUTO RECEIVABLES CO, 424B5, 1996-12-10
Next: AETNA SERIES FUND INC, 485BPOS, 1996-12-10



                                                   UNITED STATES
                          SECURITIES AND EXCHANGE COMMISSION
                                              Washington, D.C. 20549

                                                     FORM 10-Q/A

[X]	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
                       OF THE SECURITIES EXCHANGE ACT OF 1934 
For the quarterly period ended June 30, 1996
OR
[  ]	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
		OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from 		to 	

Commission file number 0-20654

                           HEALTHTECH INTERNATIONAL, INC.
                Nevada					  36-3797495	
(State or other jurisdiction of		                         (I.R.S. Employer
incorporation or organization)		                          Identification No.)

                                  1237 South Val Vista Drive
                                       Mesa, Arizona 85204
                         (Address of principal executive offices)

                                           602-396-0660
                (Registrant's telephone number, including area code)

	Indicate by check mark whether the registrant (1) has filed all reports 
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the 
registrant was required to file such reports), and (2) has been subject to 
such filing requirements for the past 90 days.
Yes  X		No____

APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPCY
PROCEEDINGS DURING THE PRECEDING FIVE YEARS:

	Indicate by check mark whether the registrant has filed all documents and 
reports required to be filed by Sections 12, 13 or 15(d) of the Securities 
Act of 1934 subsequent to the distribution of securities under a plan 
confirmed by a court.
Yes____ 	No____

APPLICABLE ONLY TO CORPORATE ISSUERS:
	
	Indicate the number of shares outstanding of each of the issuer's classes of
 common stock, as of the latest practicable date:
As of June 30, 1996, Registrant has a total of 4,843,424 common stock and 
3,616,239 class A warrants outstanding.


Signatures

Pursuant to the requirements of Section 13 or 15(d)of the Securities 
Exchange Act of 1934, the Registrant has duly caused this report to be 
signed on its behalf by the undersigned, thereunto duly authorized.

					HEALTHTECH INTERNATIONAL, INC.






		Date:  August 28, 1996		/s/ Gordon L. Hall
                        						Gordon L. Hall
					                        	Chairman of the Board of Directors


		Date:  August 28, 1996		/s/ Timothy Williams
                        						Timothy Williams
                          				President and Director 


		Date: August 28, 1996		/s/ Perry Dusch
                       						Perry Dusch
                        					Director




<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THE SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED
FROM HEALTHTECH INTERNATIONAL, INC.'S CONSOLIDATED BALANCE SHEET
AND CONSOLIDATED STATEMENTS OF OPERATION FOR THE PERIOD ENDED
JUNE 30, 1996, AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE
TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
       
<S>                             <C>                     <C>
<PERIOD-TYPE>                   3-MOS                   9-MOS
<FISCAL-YEAR-END>                          SEP-30-1996             SEP-30-1996
<PERIOD-END>                               JUN-30-1996             JUN-30-1996
<CASH>                                         109,608                 109,608
<SECURITIES>                                         0                       0
<RECEIVABLES>                                  659,629                 659,629
<ALLOWANCES>                                         0                       0
<INVENTORY>                                    100,930                 100,930
<CURRENT-ASSETS>                             1,430,915               1,430,915
<PP&E>                                      13,015,253              13,015,253
<DEPRECIATION>                                 147,045                 428,753
<TOTAL-ASSETS>                              24,056,653              24,056,653
<CURRENT-LIABILITIES>                        3,801,652               3,801,652
<BONDS>                                              0                       0
                                0                       0
                                         19                      19
<COMMON>                                         4,488                   4,488
<OTHER-SE>                                           0                       0
<TOTAL-LIABILITY-AND-EQUITY>                24,056,653              24,056,653
<SALES>                                        936,543               3,266,585
<TOTAL-REVENUES>                               936,543               3,266,585
<CGS>                                           74,737                 692,768
<TOTAL-COSTS>                                1,064,809               4,150,955
<OTHER-EXPENSES>                                     0                       0
<LOSS-PROVISION>                                     0                       0
<INTEREST-EXPENSE>                             134,705                 260,433
<INCOME-PRETAX>                              (128,266)               (884,370)
<INCOME-TAX>                                         0               (202,706)
<INCOME-CONTINUING>                          (128,266)               (681,664)
<DISCONTINUED>                                       0                       0
<EXTRAORDINARY>                                150,000                 450,000
<CHANGES>                                            0                       0
<NET-INCOME>                                    21,734               (231,664)
<EPS-PRIMARY>                                      .01                  (0.06)
<EPS-DILUTED>                                      .01                  (0.06)
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission